Search research articles
Contact Us
Filters
Showing results (111-120 of 165) with videos related to
Page
of 17
Sort By:
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1993
Monoclonal antibodies to arginine vasopressin receptor bind to liver, kidney and pituitary membranes
D Trinder, V Mooser, P A Phillips, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 1992
Isolation and characterization of the rat liver AVP receptor using [125I][d(CH2)5'sarcosine7]AVP
D Trinder, J M Kelly, R Fernley, et al.
Clinical Science (London, England : 1979)
|
June 1, 1985
Angiotensin II-induced thirst and vasopressin release in man
P A Phillips, B J Rolls, J G Ledingham, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 1, 1993
Effects of an orally active vasopressin V1 receptor antagonist
L M Burrell, P A Phillips, J Stephenson, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1994
Effects of anti-emetics on water excretion in humans
P A Phillips, L M Burrell, J Risvanis, et al.
Kidney International
|
April 1, 1994
Epidermal growth factor antagonizes vasopressin in vivo and in vitro
P A Phillips, S L Grant, A F Davidson, et al.
Endocrinology
|
March 1, 1990
Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands
P A Phillips, J M Abrahams, J M Kelly, et al.
The Journal of Endocrinology
|
August 1, 1993
Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat
L M Burrell, P A Phillips, J Stephenson, et al.
The American Journal of Medicine
|
December 26, 1989
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists
C I Johnston, P G Hodsman, M Kohzuki, et al.
Journal of Travel Medicine
|
October 17, 1998
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy
P A Phillips-Howard, R Steffen, L Kerr, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 165) with videos related to
Sort By:
Page
of 17
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1993
Monoclonal antibodies to arginine vasopressin receptor bind to liver, kidney and pituitary membranes
D Trinder, V Mooser, P A Phillips, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 1992
Isolation and characterization of the rat liver AVP receptor using [125I][d(CH2)5'sarcosine7]AVP
D Trinder, J M Kelly, R Fernley, et al.
Clinical Science (London, England : 1979)
|
June 1, 1985
Angiotensin II-induced thirst and vasopressin release in man
P A Phillips, B J Rolls, J G Ledingham, et al.
Clinical and Experimental Pharmacology & Physiology
|
May 1, 1993
Effects of an orally active vasopressin V1 receptor antagonist
L M Burrell, P A Phillips, J Stephenson, et al.
Clinical and Experimental Pharmacology & Physiology
|
January 1, 1994
Effects of anti-emetics on water excretion in humans
P A Phillips, L M Burrell, J Risvanis, et al.
Kidney International
|
April 1, 1994
Epidermal growth factor antagonizes vasopressin in vivo and in vitro
P A Phillips, S L Grant, A F Davidson, et al.
Endocrinology
|
March 1, 1990
Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands
P A Phillips, J M Abrahams, J M Kelly, et al.
The Journal of Endocrinology
|
August 1, 1993
Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the rat
L M Burrell, P A Phillips, J Stephenson, et al.
The American Journal of Medicine
|
December 26, 1989
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists
C I Johnston, P G Hodsman, M Kohzuki, et al.
Journal of Travel Medicine
|
October 17, 1998
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy
P A Phillips-Howard, R Steffen, L Kerr, et al.
Page
of 17